Toinv

Resverlogix is thought provoking for sure.

Having been fed a steady diet of forward looking statements - most recently - a 100 patient PII Covid-19 trial starting in a matter of weeks, Covid patients cured in 2 days, 4th quarter 2021 revenues, commercialization, Eversana product roll-out, our drug works, a valuation that far exceeds the share price, a wealthy Saudi investor who wishes to increase his initially proposed investment for this miraculous new therapeutic, and on and on and on ......... , still no answers from management, no follow-up communication, a veil of secrecy shrouds their endeavors - if there are any. My thoughts turn to anger and despair each time I view my RVX holdings.

Your comments re: HEPA are well-taken - perhaps that is and has been the only BP alluded to in management's forward looking statements.

Resverlogix needs a change in leadership, a viable business plan,  resolve in completing it's goals, accountability, improved communications.